• Oct 06, 2013 | Webcast

    Sclerostin: The Journey from Discovery to Application

    Bejamin Leder, MD; Michaela Kneissel, PhD; Socrates Papapoulos, MD; Matthew Drake, MD, PhD; John Bilezikian, MD
    Molecular Cellular and Genetic Determinants of Bone Structure and Formation

    Chairs:
    Benjamin Leder, M.D.
    Massachusetts General Hospital, Harvard Medical School, USA

    Michaela Kneissel, Ph.D.
    Novartis Institutes for Biomedical Research, Switzerland

    Speakers:
    Lessons from Human Genetic Diseases (Not included in webcast)
    Socrates Papapoulos, M.D.
    Leiden University Medical Center, The Netherlands

    Circulating Sclerostin as a Marker of Bone Health and Disease
    Matthew Drake, M.D., Ph.D.
    College of Medicine, Mayo Clinic, USA

    Sclerostin Antagonism: Clinical Applications and Therapeutic Potential
    John Bilezikian, M.D.
    Columbia University College of Physicians and Surgeons, USA

    Supported by educational grants from Lilly USA, LLC and Merck & Co., Inc.

    Length: 60 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details